Dangerous convergence: COVID-19, substandard antibiotics and AMR

  26 June 2020

Unfortunately, antibiotics are often overused and overprescribed during emergencies, even when they are least likely to be effective. The ongoing COVID-19 pandemic is one such instance. A recent report showed that doctors heavily prescribed antibiotics in the beginning of the pandemic, desperate to try to help in any way by preventing secondary bacterial infections. 

This excessive use of antibiotics increases the risk of AMR and serves as another lesson about prudent antibiotic usage. The use of antibiotics during the previous SARS epidemic resulted in a sharp local rise in AMR. The World Health Organization (WHO), concerned about the increased antibiotic usage, has issued guidance to not use antibiotic therapy or prophylaxis in mild COVID-19 patients. 

Further reading: Quality Matters
Author(s): Quality Matters
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!